Tuberculosis: $242bn investment required to attain 2030 target

Not making the funds available will be more expensive and air-borne disease with drug-resistant variants can go out of control

To achieve the 2030 target of reducing the incidence of Tuberculosis (TB) to as low as 20 per 100,000, global investment worth $242 billion would be required for diagnosis, treatments and prevention over the next eight years. Suvanand Sahu, the deputy executive, Stop TB Partnership, an advocacy g

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```